Kayne Anderson Rudnick Investment Management’s West Pharmaceutical WST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230M | Buy |
1,051,330
+53,448
| +5% | +$11.7M | 0.55% | 61 |
|
|
2025
Q1 | $223M | Buy |
997,882
+365,575
| +58% | +$81.8M | 0.55% | 58 |
|
|
2024
Q4 | $207M | Buy |
632,307
+21,806
| +4% | +$7.14M | 0.48% | 69 |
|
|
2024
Q3 | $183M | Buy |
610,501
+16,809
| +3% | +$5.05M | 0.4% | 69 |
|
|
2024
Q2 | $196M | Buy |
593,692
+37,702
| +7% | +$12.4M | 0.48% | 67 |
|
|
2024
Q1 | $220M | Buy |
555,990
+110,413
| +25% | +$43.7M | 0.51% | 60 |
|
|
2023
Q4 | $157M | Buy |
445,577
+30,902
| +7% | +$10.9M | 0.39% | 75 |
|
|
2023
Q3 | $156M | Sell |
414,675
-71,135
| -15% | -$26.7M | 0.44% | 65 |
|
|
2023
Q2 | $186M | Buy |
485,810
+25,642
| +6% | +$9.81M | 0.52% | 60 |
|
|
2023
Q1 | $159M | Buy |
460,168
+23,411
| +5% | +$8.11M | 0.47% | 62 |
|
|
2022
Q4 | $103M | Buy |
436,757
+124,874
| +40% | +$29.4M | 0.32% | 88 |
|
|
2022
Q3 | $76.7M | Buy |
311,883
+23,334
| +8% | +$5.74M | 0.25% | 108 |
|
|
2022
Q2 | $87.2M | Buy |
288,549
+4,399
| +2% | +$1.33M | 0.28% | 101 |
|
|
2022
Q1 | $117M | Buy |
284,150
+14,823
| +6% | +$6.09M | 0.31% | 97 |
|
|
2021
Q4 | $126M | Sell |
269,327
-91,934
| -25% | -$43.1M | 0.29% | 99 |
|
|
2021
Q3 | $153M | Buy |
361,261
+18,616
| +5% | +$7.9M | 0.37% | 85 |
|
|
2021
Q2 | $123M | Buy |
342,645
+74,247
| +28% | +$26.7M | 0.3% | 99 |
|
|
2021
Q1 | $75.6M | Buy |
268,398
+21,160
| +9% | +$5.96M | 0.2% | 117 |
|
|
2020
Q4 | $70M | Buy |
247,238
+13,468
| +6% | +$3.82M | 0.2% | 116 |
|
|
2020
Q3 | $64.3M | Buy |
233,770
+14,748
| +7% | +$4.05M | 0.23% | 104 |
|
|
2020
Q2 | $49M | Buy |
219,022
+14,974
| +7% | +$3.35M | 0.2% | 106 |
|
|
2020
Q1 | $31.1M | Buy |
204,048
+9,885
| +5% | +$1.51M | 0.18% | 111 |
|
|
2019
Q4 | $29.2M | Buy |
194,163
+19,293
| +11% | +$2.9M | 0.14% | 127 |
|
|
2019
Q3 | $24.8M | Buy |
174,870
+12,380
| +8% | +$1.76M | 0.13% | 122 |
|
|
2019
Q2 | $20.3M | Buy |
162,490
+20,272
| +14% | +$2.54M | 0.11% | 132 |
|
|
2019
Q1 | $15.7M | Buy |
142,218
+13,549
| +11% | +$1.49M | 0.09% | 136 |
|
|
2018
Q4 | $12.6M | Buy |
128,669
+26,425
| +26% | +$2.59M | 0.09% | 143 |
|
|
2018
Q3 | $12.6M | Buy |
102,244
+15,049
| +17% | +$1.86M | 0.07% | 158 |
|
|
2018
Q2 | $8.66M | Buy |
87,195
+42,949
| +97% | +$4.26M | 0.06% | 178 |
|
|
2018
Q1 | $3.91M | Buy |
44,246
+7,771
| +21% | +$686K | 0.03% | 209 |
|
|
2017
Q4 | $3.6M | Buy |
36,475
+1,536
| +4% | +$152K | 0.03% | 214 |
|
|
2017
Q3 | $3.36M | Buy |
34,939
+419
| +1% | +$40.3K | 0.03% | 214 |
|
|
2017
Q2 | $3.26M | Buy |
34,520
+3,560
| +11% | +$337K | 0.03% | 216 |
|
|
2017
Q1 | $2.53M | Buy |
30,960
+4,787
| +18% | +$391K | 0.03% | 236 |
|
|
2016
Q4 | $2.22M | Buy |
26,173
+5,099
| +24% | +$433K | 0.03% | 245 |
|
|
2016
Q3 | $1.57M | Buy |
+21,074
| New | +$1.57M | 0.02% | 261 |
|